Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population

D J McDonagh, S P Nathan, R J Knudson, M D Lebowitz, D J McDonagh, S P Nathan, R J Knudson, M D Lebowitz

Abstract

For plethysmographic studies of lung mechanics and measurement of pulmonary diffusing capacity, 62 subjects were drawn from a randomly selected population sample. Data obtained from the 24 subjects of heterozygous phenotype for alpha-1-antitrypsin deficiency (PiMZ) were compared by age group with data from 38 normal (PiM) subjects matched for sex, age, and smoking history. Comparison of mean values by age group for lung volumes, diffusing capacity, lung elastic recoil, maximum expiratory flow, and the occurrence of frequency dependence of dynamic compliance revealed no differences between phenotype groups. There was no evidence of an accelerated effect of aging among PiMZ subjects when compared with normal counterparts nor was there evidence of an increased effect of smoking. From these data it appears that the PiMZ phenotype per se is not a risk factor in the development of emphysema.

References

    1. Acta Med Scand. 1964 Feb;175:197-205
    1. J Appl Physiol. 1964 Mar;19:207-11
    1. J Clin Invest. 1957 Jan;36(1 Part 1):1-17
    1. J Clin Invest. 1956 Mar;35(3):322-6
    1. Am Rev Respir Dis. 1978 Jan;117(1):179-81
    1. Bull Eur Physiopathol Respir. 1978 Jan-Feb;14(1):11-22
    1. Am Rev Respir Dis. 1978 Mar;117(3):421-8
    1. Am Rev Respir Dis. 1978 Feb;117(2):239-45
    1. N Engl J Med. 1977 May 26;296(21):1190-4
    1. Br Med J. 1977 Oct 8;2(6092):922-5
    1. Am J Med. 1977 Jan;62(1):93-8
    1. J Appl Physiol Respir Environ Exerc Physiol. 1977 Dec;43(6):1054-62
    1. J Clin Invest. 1976 Nov;58(5):1069-77
    1. Am Rev Respir Dis. 1976 Nov;114(5):945-53
    1. Am Rev Respir Dis. 1973 Jan;107(1):50-63
    1. Am Rev Respir Dis. 1974 Dec;110(6):708-15
    1. Ann Intern Med. 1971 May;74(5):672-80
    1. Clin Chim Acta. 1967 May;16(2):199-203
    1. Am Rev Respir Dis. 1975 Jul;112(1):71-5
    1. Am Rev Respir Dis. 1973 Oct;108(4):918-25
    1. J Appl Physiol. 1974 Oct;37(4):600-3
    1. J Appl Physiol. 1973 Aug;35(2):304-6
    1. Am Rev Respir Dis. 1973 Feb;107(2):289-91
    1. Am Rev Respir Dis. 1972 Sep;106(3):377-83
    1. N Engl J Med. 1972 Nov 23;287(21):1067-9
    1. Am Rev Respir Dis. 1969 Nov;100(5):619-25
    1. Anal Biochem. 1976 Jul;74(1):227-41
    1. Johns Hopkins Med J. 1975 Sep;137(3):95-104
    1. N Engl J Med. 1975 Feb 6;292(6):278-81
    1. Am Rev Respir Dis. 1976 May;113(5):601-6
    1. Am Rev Respir Dis. 1975 May;111(5):587-93
    1. Thorax. 1976 Apr;31(2):149-57
    1. Am Rev Respir Dis. 1976 May;113(5):587-600
    1. Am Rev Respir Dis. 1976 Mar;113(3):261-6
    1. Am J Epidemiol. 1975 Aug;102(2):137-52
    1. J Appl Physiol. 1975 Jan;38(1):64-9
    1. Ann Intern Med. 1970 May;72(5):627-32
    1. J Appl Physiol. 1968 Dec;25(6):664-71
    1. Am Rev Respir Dis. 1968 Oct;98(4):692-6
    1. Arch Intern Med. 1968 Sep;122(3):254-7
    1. J Appl Physiol. 1967 Jan;22(1):95-108
    1. Am Rev Respir Dis. 1966 Oct;94(4):529-39

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere